Intellia Therapeutics Inc buy Oppenheimer Holdings Inc.
Start price
13.11.23
/
50%
€22.25
Target price
13.11.24
€65.39
Performance (%)
8.49%
Price
17.05.24
€24.14
Summary
This prediction is currently active. With a performance of 8.49%, the BUY prediction by Oppenheimer_Holdings for Intellia Therapeutics Inc is trending in the right direction. This prediction currently runs until 13.11.24. The prediction end date can be changed by Oppenheimer_Holdings at any time. Oppenheimer_Holdings has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Intellia Therapeutics Inc | 6.250% | 6.250% |
iShares Core DAX® | -0.383% | 5.404% |
iShares Nasdaq 100 | 1.248% | 6.732% |
iShares Nikkei 225® | 0.525% | 1.840% |
iShares S&P 500 | 0.640% | 4.710% |
Comments by Oppenheimer_Holdings for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics, Inc. (NASDAQ: NTLA) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $80.00 to $70.00. They now have an "outperform" rating on the stock.
Ratings data for NTLA provided by MarketBeat